IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

HY V PHAN

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1144373408
CMS profile
851126
Location
SAN DIEGO, CA

General Payments · PY2018–2024

$6,005.43

  • Reported across 289 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,099.16

46 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatry CA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,099.16 46

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Neurocrine BioSciences, Inc. $179.97 10
ITI, Inc. $169.12 6
Otsuka America Pharmaceutical, Inc. $139.85 6
Teva Pharmaceuticals USA, Inc. $134.48 5
Janssen Pharmaceuticals, Inc $119.07 4
Indivior Inc. $98.17 4
Vanda Pharmaceuticals Inc. $71.80 2
Tempus AI, Inc $59.89 2
Alkermes, Inc. $53.87 3
ABBVIE INC. $51.83 3
Takeda Pharmaceuticals U.S.A., Inc. $21.11 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $814.08 47
PY2019 $758.60 47
PY2020 $555.72 25
PY2021 $720.86 38
PY2022 $930.57 43
PY2023 $1,126.44 43
PY2024 $1,099.16 46

Payment records · PY2024 (46)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $17.42 02/09/2024 Food and Beverage Undisputed 01/23/2026 1105258529 CMS
ABBVIE INC. $17.02 04/17/2024 Food and Beverage Undisputed 01/23/2026 1105258533 CMS
ABBVIE INC. $17.39 06/12/2024 Food and Beverage Undisputed 01/23/2026 1105258537 CMS
Alkermes, Inc. $17.55 01/03/2024 Food and Beverage Undisputed 01/23/2026 1120573111 CMS
Alkermes, Inc. $13.62 06/05/2024 Food and Beverage Undisputed 01/23/2026 1120573113 CMS
Alkermes, Inc. $22.70 09/04/2024 Food and Beverage Undisputed 01/23/2026 1120573115 CMS
Indivior Inc. $22.11 02/01/2024 Food and Beverage Undisputed 01/23/2026 1144535539 CMS
Indivior Inc. $25.76 03/14/2024 Food and Beverage Undisputed 01/23/2026 1144535541 CMS
Indivior Inc. $26.75 05/04/2024 Food and Beverage Undisputed 01/23/2026 1144535543 CMS
Indivior Inc. $23.55 06/21/2024 Food and Beverage Undisputed 01/23/2026 1144535545 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $30.36 02/28/2024 Food and Beverage Undisputed 01/23/2026 1143295920 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $29.81 03/27/2024 Food and Beverage Undisputed 01/23/2026 1143295923 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $27.34 06/26/2024 Food and Beverage Undisputed 01/23/2026 1143295927 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $28.40 09/11/2024 Food and Beverage Undisputed 01/23/2026 1143295931 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.07 09/27/2024 Food and Beverage Undisputed 01/23/2026 1143295935 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $30.14 11/20/2024 Food and Beverage Undisputed 01/23/2026 1143295938 CMS
Janssen Pharmaceuticals, Inc $36.25 07/10/2024 Food and Beverage Undisputed 01/23/2026 1077939428 CMS
Janssen Pharmaceuticals, Inc $31.58 10/08/2024 Food and Beverage Undisputed 01/23/2026 1077939416 CMS
Janssen Pharmaceuticals, Inc $28.62 11/06/2024 Food and Beverage Undisputed 01/23/2026 1077939324 CMS
Janssen Pharmaceuticals, Inc $22.62 11/27/2024 Food and Beverage Undisputed 01/23/2026 1077939066 CMS
Neurocrine Biosciences, Inc. $25.92 02/02/2024 Food and Beverage Undisputed 01/23/2026 1150837305 CMS
Neurocrine Biosciences, Inc. $0.60 02/02/2024 Food and Beverage Undisputed 01/23/2026 1150892635 CMS
Neurocrine Biosciences, Inc. $0.39 02/02/2024 Food and Beverage Undisputed 01/23/2026 1150892769 CMS
Neurocrine Biosciences, Inc. $27.00 04/19/2024 Food and Beverage Undisputed 01/23/2026 1150833682 CMS
Neurocrine Biosciences, Inc. $1.03 04/19/2024 Food and Beverage Undisputed 01/23/2026 1150892297 CMS
Neurocrine Biosciences, Inc. $22.91 04/24/2024 Food and Beverage Undisputed 01/23/2026 1150846811 CMS
Neurocrine Biosciences, Inc. $32.40 07/17/2024 Food and Beverage Undisputed 01/23/2026 1150822288 CMS
Neurocrine Biosciences, Inc. $22.45 07/31/2024 Food and Beverage Undisputed 01/23/2026 1150849252 CMS
Neurocrine Biosciences, Inc. $26.83 08/21/2024 Food and Beverage Undisputed 01/23/2026 1150834040 CMS
Neurocrine Biosciences, Inc. $20.44 12/11/2024 Food and Beverage Undisputed 01/23/2026 1150856808 CMS
Otsuka America Pharmaceutical, Inc. $29.83 02/21/2024 Food and Beverage Undisputed 01/23/2026 1118961019 CMS
Otsuka America Pharmaceutical, Inc. $21.00 03/20/2024 Food and Beverage Undisputed 01/23/2026 1118961021 CMS
Otsuka America Pharmaceutical, Inc. $29.09 05/29/2024 Food and Beverage Undisputed 01/23/2026 1118961023 CMS
Otsuka America Pharmaceutical, Inc. $19.91 08/28/2024 Food and Beverage Undisputed 01/23/2026 1118961025 CMS
Otsuka America Pharmaceutical, Inc. $18.20 09/17/2024 Food and Beverage Undisputed 01/23/2026 1118961027 CMS
Otsuka America Pharmaceutical, Inc. $21.82 12/06/2024 Food and Beverage Undisputed 01/23/2026 1118961029 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.11 07/03/2024 Food and Beverage Undisputed 01/23/2026 1137653902 CMS
Tempus AI, Inc $30.94 07/24/2024 Food and Beverage Undisputed 01/23/2026 1150171965 CMS
Tempus AI, Inc $28.95 08/30/2024 Food and Beverage Undisputed 01/23/2026 1150171967 CMS
Teva Pharmaceuticals USA, Inc. $29.80 04/03/2024 Food and Beverage Undisputed 01/23/2026 1151585338 CMS
Teva Pharmaceuticals USA, Inc. $20.13 05/22/2024 Food and Beverage Undisputed 01/23/2026 1151585356 CMS
Teva Pharmaceuticals USA, Inc. $32.50 06/07/2024 Food and Beverage Undisputed 01/23/2026 1151585358 CMS
Teva Pharmaceuticals USA, Inc. $28.80 06/13/2024 Food and Beverage Undisputed 01/23/2026 1151585360 CMS
Teva Pharmaceuticals USA, Inc. $23.25 12/18/2024 Food and Beverage Undisputed 01/23/2026 1151585440 CMS
Vanda Pharmaceuticals Inc. $38.33 03/02/2024 Food and Beverage Undisputed 01/23/2026 1133916429 CMS
Vanda Pharmaceuticals Inc. $33.47 10/23/2024 Food and Beverage Undisputed 01/23/2026 1133916431 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.